N
GNMK

Nuveen’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nuveen’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-656,928
Closed -$15.7M – 3650
2021
Q1 		$15.7M Sell
656,928
-459,795
-41% -$8.55M 0.01% 1497
2020
Q4 		$16.3M Sell
1,116,723
-87,064
-7% -$1.15M 0.01% 1375
2020
Q3 		$17.1M Buy
1,203,787
+491,048
+69% +$7.5M 0.01% 1164
2020
Q2 		$10.5M Buy
712,739
+97,886
+16% +$995K ﹤0.01% 1453
2020
Q1 		$2.53M Buy
614,853
+9,181
+2% +$43K ﹤0.01% 2073
2019
Q4 		$2.91M Buy
605,672
+124,900
+26% +$689K ﹤0.01% 2262
2019
Q3 		$2.91M Buy
480,772
+64,636
+16% +$403K ﹤0.01% 2231
2019
Q2 		$2.7M Buy
+416,136
New +$2.93M ﹤0.01% 2285

Nuveen's GNMK Position: Q2 2021 in Review

Nuveen sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 656,928 shares — an estimated $15.7M sold.

Nuveen first reported a position in GNMK in Q2 2019 and held it in 8 quarters. The position peaked at $17.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Nuveen reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 656,928 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $15.7M.
  • Nuveen first reported a position in GenMark Diagnostics, Inc in Q2 2019 and held it in 8 quarters.
  • Nuveen's GenMark Diagnostics, Inc position peaked at $17.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.